These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7407943)

  • 21. Regulation of the immune response to tumor antigens. II. The nature of immunosuppressor cells in tumor-bearing hosts.
    Fujimoto S; Greene MI; Sehon AH
    J Immunol; 1976 Mar; 116(3):800-6. PubMed ID: 1254955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
    Yoshida R; Yoneda Y; Kuriyama M; Kubota T
    J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts.
    Fujimoto S; Greene MI; Sehon AH
    J Immunol; 1976 Mar; 116(3):791-9. PubMed ID: 1082894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The development and specific suppression of concomitant immunity in two syngeneic tumour-host systems.
    Chandradasa KD
    Int J Cancer; 1973 May; 11(3):648-62. PubMed ID: 4598551
    [No Abstract]   [Full Text] [Related]  

  • 25. Modification by passive IgM of the immune response of mice to a tumor allograft.
    Cantrell JL; Kaliss N
    J Natl Cancer Inst; 1974 May; 52(5):1619-25. PubMed ID: 4831447
    [No Abstract]   [Full Text] [Related]  

  • 26. Rejection of allogeneic and syngeneic but not MHC class I-deficient tumor grafts by MHC class I-deficient mice.
    Freland S; Chambers BJ; Andersson M; Van Kaer L; Ljunggren HG
    J Immunol; 1998 Jan; 160(2):572-9. PubMed ID: 9551890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The ultrastructure of sarcoma I cells and immune macrophages during their interaction in the peritoneal cavities of immune C57BL-6 mice.
    Chambers VC; Weiser RS
    Cancer Res; 1972 Feb; 32(2):413-9. PubMed ID: 5058195
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunogenic properties of a soluble tumor rejection antigen (TSTA) from a Simian virus 40-induced sarcoma.
    Rogers MJ; Law LW
    Int J Cancer; 1979 Jan; 23(1):89-96. PubMed ID: 83307
    [No Abstract]   [Full Text] [Related]  

  • 29. Lysozyme enhancement of tumor cell immunoprotection in a murine fibrosarcoma.
    Warren JS; Rinehart JJ; Zwilling BS; Neidhart JA
    Cancer Res; 1981 May; 41(5):1642-5. PubMed ID: 7214334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biologic and biochemical properties of detergent-solubilized tumor-specific transplantation antigen from a simian virus 40-induced neoplasm: brief communication.
    Natori T; Law LW; Appella E
    J Natl Cancer Inst; 1977 Oct; 59(4):1331-3. PubMed ID: 198560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-specific and allospecific immunogenicity of soluble extracts from chemically induced murine sarcomas.
    Pellis NR; Tom BH; Kahan BD
    J Immunol; 1974 Aug; 113(2):708-11. PubMed ID: 4136043
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies of allogeneic tumor transplants: induced rejection of advanced tumors by immune alteration of recipients.
    Russell PS; Chase CM; Burton RC
    J Immunol; 1983 Feb; 130(2):951-7. PubMed ID: 6336775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the immunosuppressive drug niridazole in isogeneic and allogeneic mouse tumor systems in vivo.
    Deodhar SD; Lee VW; Chiang T; Mahmoud AF; Watten KS
    Cancer Res; 1976 Sep; 36(9 pt.1):3147-50. PubMed ID: 975080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum lysozyme as a marker of host resistance. I. Production by macrophages resident in rat sarcomata.
    Currie GA; Eccles SA
    Br J Cancer; 1976 Jan; 33(1):51-9. PubMed ID: 766806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of active immune state by multinucleate tumour cells in mice.
    Liao SK; Carr DH
    Experientia; 1973 May; 29(5):597-9. PubMed ID: 4354198
    [No Abstract]   [Full Text] [Related]  

  • 36. Rejection of long-surviving mouse skin allografts after withdrawal of cyclosporin A therapy.
    Lems SP; Capel PJ; Koene RA
    Transplant Proc; 1980 Jun; 12(2):283-6. PubMed ID: 6994296
    [No Abstract]   [Full Text] [Related]  

  • 37. Biological and biochemical properties of Nonidet P40-solubilized and partially purified tumor-specific antigens of the transplantation type from plasma membranes of a methylcholanthrene-induced sarcoma.
    Natori T; Law LW; Appella E
    Cancer Res; 1977 Sep; 37(9):3406-13. PubMed ID: 69494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A technique for liver transplantation in the inbred mouse.
    Searle RF; Flaks B
    Transplantation; 1976 Sep; 22(3):256-64. PubMed ID: 788251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of simian virus 40 (SV40) transplantation immunity in mice by SV40-transformed cells of various species.
    Law LW; Takemoto KK; Rogers MJ; Ting RC
    J Natl Cancer Inst; 1977 Nov; 59(5):1523-6. PubMed ID: 198568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolongation of mouse heart allograft survival by prior administration of nonspecific blood.
    Kelley SE; Corry RJ
    Transplant Proc; 1981 Mar; 13(1 Pt 1):518-22. PubMed ID: 7022885
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.